Claudio Sorino

Prof. Dr. Claudio Sorino

S. Anna Hospital, Department of Pulmonology, Azienda Socio Sanitaria Territoriale Lariana, Como, Lombardy, Italy
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2018 in Clinical Infectious Diseases
Verified
Journal Article
Open access
MPMarta Di Pasquale
Marta Di Pasquale
GSGiovanni Sotgiu
Giovanni Sotgiu
AGAndrea Gramegna
Andrea Gramegna
DRDejan Radovanovic
Dejan Radovanovic
STSilvia Terraneo
Silvia Terraneo
LLLucía Labra
Lucía Labra
Background: The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods: We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results: At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). Conclusions: Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.

1 December 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SAStefano Aliberti
Stefano Aliberti
LRLuis F Reyes
Luis F Reyes
Paola FaverioPaola Faverio
Paola Faverio
GSGiovanni Sotgiu
Giovanni Sotgiu
SDSimone Dore
Simone Dore
LLLucía Labra
Lucía Labra

1 May 2020 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Claudio SorinoClaudio Sorino
Claudio Sorino
SNStefano Negri
Stefano Negri
ASAntonio Spanevello
Antonio Spanevello
DVDina Visca
Dina Visca
Nicola ScichiloneNicola Scichilone
Nicola Scichilone

1 June 2010 in Allergy
Verified
Journal Article
Closed access
PDF file
Nicola ScichiloneNicola Scichilone
Nicola Scichilone
SBSalvatore Battaglia
Salvatore Battaglia
Claudio SorinoClaudio Sorino
Claudio Sorino
GPG. Paglino
G. Paglino
LML. Martino
L. Martino
VBV. Bellia
V. Bellia

1 January 2008 in Thorax
Verified
Journal Article
Closed access
PDF file
VBV Bellia
V Bellia
Claudio SorinoClaudio Sorino
Claudio Sorino
FCF Catalano
F Catalano
GAG Augugliaro
G Augugliaro
Nicola ScichiloneNicola Scichilone
Nicola Scichilone
Raffaele Antonelli IncalziRaffaele Antonelli Incalzi
Raffaele Antonelli Incalzi
Background: Forced expiratory volume in 6 s (FEV6) has been proposed as a more easily measurable parameter than forced vital capacity (FVC) to diagnose airway disease using spirometry. A study was undertaken to estimate FEV6 repeatability, to identify correlates of a good quality FEV6 measurement and of volumetric differences between FEV6 and FVC in elderly patients. Methods: 1531 subjects aged 65–100 years enrolled in the SA.R.A project (a cross-sectional multicentre non-interventional study) were examined. FEV6 was measured on volume-time curves that achieved satisfactory start-of-test and end-of-test criteria. Correlates of FEV6 achievement were assessed by logistic regression. Results: Valid FEV6 and FVC measurements were obtained in 82.9% and 56.9%, respectively, of spirometric tests with an acceptable start-of-test criterion. Female sex, older age, lower educational level, depression, cognitive impairment and lung restriction independently affected the achievement of FEV6 measurement. Good repeatability (difference between the best two values <150 ml) was found in 91.9% of tests for FEV6 and in 86% for FVC; the corresponding figures in patients with airway obstruction were 94% and 78.4%. Both FEV6 and FVC repeatability were affected by male sex and lower education. Male sex, airway obstruction and smoking habit were independently associated with greater volumetric differences between FEV6 and FVC. Conclusions: In elderly patients, FEV6 measurements are more easily achievable and more reproducible than FVC although 1/6 patients in this population were unable to achieve them.

1 October 2016 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Claudio SorinoClaudio Sorino
Claudio Sorino
Claudio PedoneClaudio Pedone
Claudio Pedone
Nicola ScichiloneNicola Scichilone
Nicola Scichilone